Smart sensors aim to ease burden for dementia caregivers

NCT ID NCT05159596

Completed Symptom relief Sponsor: University of California, Berkeley Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested an in-home technology system designed to help Spanish-speaking caregivers of people with dementia, Alzheimer's, or mild cognitive impairment. The system uses sensors and intelligent bots to detect worrisome behaviors like falls or wandering and sends alerts to the caregiver's phone. The goal was to see if this technology could reduce caregiver anxiety, burden, and loneliness. Only 6 caregivers participated, and the study measured changes in depression, burden, anxiety, and life satisfaction over 3 and 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: In-home sensor system with intelligent monitoring and alerts
What this could lead to: If successful, this technology could provide a practical way to ease caregiver stress and improve daily life for families caring for a loved one with dementia.
What could go wrong: This was a very small study with only 6 participants, so results may not apply to all caregivers. The technology also depends on reliable internet and smartphone use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE DEMENTIA MILD COGNITIVE IMPAIRMENT

Contacts and locations

Locations

University of California, Berkeley

Berkeley, California, 94720, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.